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Abstract In order to better understand the contribution of the
knotted folding pattern to the enzymatic and mechanical
properties of carbonic anhydrases, we replaced Gln-253 of
bovine carbonic anhydrase II with Cys, which allowed us to
measure the mechanical strength of the protein against tensile
deformation by avoiding knot tightening. The expressed protein,
to our surprise, turned out to contain two conformational
isomers, one capable of binding an enzymatic inhibitor and the
other not, which led to their separation through affinity
chromatography. In near- and far-UV circular dichroism and
fluorescence spectra, the separated conformers were very similar
to each other and to the wild-type enzyme, indicating that they
both had native-like conformations. We describe new evidence
which supports the notion that the difference between the two
conformers is likely to be related to the completeness of the
C-terminal knot formation. ' 2002 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
A comprehensive computational search of protein structure
databases together with our current knowledge of protein
folding indicates that few proteins have a knot topology in
their folding pattern [1,2]. Human carbonic anhydrase I and II
(collectively HCA) belong to them having similar 3D struc-
tures with root-mean-square deviations of 1.0 A9 for back bone
atoms [3^6]. The importance of the unique C-terminal folding
pattern of HCA having a trefoil knot was implicated in a
series of refolding studies done by Carlsson and his colleagues
[4,7]. They showed that human carbonic anhydrase II
(HCAII) could be refolded from the denatured state with sev-
eral distinct kinetic steps, the slowest among them having a
half-time of 9 min. Using various labeling techniques, they
showed that refolding of the C-terminal region constituted
one of the slow reactions and was almost synchronous with
the recovery of the enzymatic activity. They also showed that
proteolytic truncation of three consecutive amino acid resi-
dues from the C-terminus of HCAI under denaturing condi-
tions reduced the extent of recovery of refolded protein to
only 25% of the starting material and the refolded protein
showed decreased stability [8]. These observations on HCA
indicate that the C-terminal sequence involved in the knot
topology contains vital information for the correct folding
of the enzyme leading to the formation of an active site. In
addition to the role of knot formation in the enzymatic activ-
ity of carbonic anhydrases, we became interested in studying
the e¡ect of such a knot structure on the mechanical response
of the protein to a tensile force applied to stretch it from two
de¢ned sites. Mechanical stretching of protein molecules using
the atomic force microscope (AFM) was initiated by Mitsui et
al. [9] and has been extensively used to measure the force to
break globular units in tandemly repeated proteins such as
titin and ¢bronectin [10^12]. It seemed to us that the presence
of a knot very near to the C-terminus of carbonic anhydrases
should have a signi¢cant e¡ect on the mechanical properties
of the protein, and this would be a good test of the usefulness
of the AFM for the study of protein nanomechanics. For this
purpose, we chose the bovine homolog (BCAII) of HCAII
and its recombinant mutants as experimental materials be-
cause the protein does not have cysteine residues and refolding
studies have been done on it as extensively as on HCA [13,14].
BCAII has 259 amino acid residues with 77% sequence ho-
mology to HCAII [15], and not surprisingly it has recently
been shown that BCAII has a very similar 3D structure to
those of HCA including the C-terminal knot [16]. Wang and
Ikai reported that BCAII resisted forced unfolding on the
AFM to a remarkable degree, extending a mere 13C 2 nm
(out of the theoretical full length of 96 nm for a protein
having 259 amino acid residues) against a tensile force of
1.7 C 0.2 nN which was strong enough to break covalent cross-
linkers used to tether the molecule to the substrate [17^19].
To study the e¡ect of the knot on the mechanical response
of BCAII more precisely, we constructed a mutant protein
having a cysteine residue at the N-terminus and another at
the 253rd position replacing Gln-253 which is located close to
the C-terminus as mechanical stretching from this position
and the N-terminus should avoid knot tightening (Fig. 1).
The expressed and puri¢ed protein sample satis¢ed our ex-
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pectations of knot avoidance as it was stretched longer than
70 nm before the breakdown of the covalent crosslinking sys-
tem, but it turned out to contain two conformational isomers,
type I and II as we designated them, the former capable of
binding enzymatic inhibitors while the latter not. The two
separated isomers were found to have very similar optical
properties but their force vs. extension (F^E) behavior in me-
chanical stretching experiments is clearly di¡erent. We discuss
the signi¢cance of our new ¢ndings in relation to lines of
evidence strongly supporting the notion that type I has a
knotted C-terminal conformation while type II is most likely
unknotted. The mutant protein used in this study or closely
related ones will be a good choice for further investigation of
the e¡ect of a knot on BCAII folding and activity.
2. Materials and methods
2.1. Protein engineering
Two Cys residues were introduced at designated sites of the bovine
carbonic anhydrase II (BCAII) by using a standard technique [20].
Escherichia coli strain BL21 (DE3) (Novagen, Madison, WI, USA)
was used to overexpress the mutant gene cloned in the pRSETB
vector (Invitrogen, San Diego, CA, USA) following a procedure re-
ported earlier [21]. The expressed His6-tagged mutant protein was
preliminarily puri¢ed by metal chelate a⁄nity chromatography using
a Ni-NTA agarose column (Qiagen, Hilden, Germany) and the purity
of the protein preparation was s 97% as determined by SDS^PAGE.
The expressed protein contained 36 extra amino acid residues includ-
ing an enterokinase recognition sequence and six histidine residues at
N-terminal. The presence of the long extra peptide did not interfere
with the activity of the enzyme. The protein was kept in 50 mM Tris^
SO4 (pH 7.5) bu¡er containing 5 mM DTT at 4‡C and the reducing
reagent together with remaining impurities were removed with Super-
dex 75 HR 10/30 (Amersham Pharmacia Biotech, Uppsala, Sweden)
column immediately before measurements of various properties of the
protein. The enzymatic activity was determined by using the esterase
reaction as described previously [22].
2.2. A⁄nity chromatography
The a⁄nity matrix (1 ml) used for separation of the two conformers
was prepared by coupling p-aminomethylbenzenesulfonamide with ac-
tivated agarose gel with amine reactive N-hydroxysuccinimide (Hi-
Trap NHS activated column, Amersham Pharmacia Biotech) accord-
ing to manufacturer’s manual. The puri¢ed enzyme was applied to the
column and eluted with 50 mM Tris^SO4 (pH 7.5) containing 0.4 M
NaN3 [23]. The releasing agent (0.4 M NaN3) in the elution was
removed with Sephadex G-25 desalting column (Amersham Pharma-
cia Biotech). In this experiment, active enzyme was not detected in the
£ow-through fraction.
2.3. Circular dichroism (CD) measurements
CD measurements were carried out on a Jasco J-720WI spectropo-
larimeter (Tokyo, Japan) with constant N2 £ushing. Far- and near-
UV CD spectra were obtained using two types of quartz cells respec-
tively having 1 and 10 mm optical path-lengths, with a sample con-
centration of 15 WM for both measurements. All the spectra given in
this paper were averages of ¢ve to eight repeated scans each at 0.5 nm
intervals and were corrected for the base line. The resulting spectra
were smoothed using the minimum ¢lter included in the instrumental
software. A spectral contribution from the extra N-terminal peptide
was subtracted as a random coil-type spectrum of the corresponding
number of amino acid residues and the resultant spectrum was ana-
lyzed for the estimation of the secondary structure by CONTIN, a
computer program that implemented the ridge regression [24]. Ellip-
ticity is reported as the mean residue molar ellipticity, [a] in degree
cm2 dmol31, calculated according to the following equation.
½a  ¼ ½a obsWmrw=10UlUc;
where [a]obs is the observed ellipticity in degrees, mrw is the mean
residue molecular weight, c is the protein concentration in g/ml and
l is the optical path-length in cm.
2.4. Force-induced mechanical measurements
The engineered protein was immobilized on a silicon surface made
reactive towards sulfhydryl groups by grafting the bifunctional cross-
linker, SPDP (N-succinimidyl-3-[2-pyridyldithio]propionate; Pierce,
Rockford, IL, USA) or NHS-PEG3400-MAL (Shearwater Polymers,
Huntsville, AL, USA) as described [21]. To ensure extension of a
single molecule at one time, the protein density on the substrate
was adjusted so that less than 10% of all force measurements gave
positive indications of protein stretching. To reduce the protein den-
sity on the surface, a mono-functional crosslinker NHS-PEG2000
(Shearwater Polymers) was simultaneously engrafted on the silicon
surface as a diluent. A similarly functionalized cantilever (NP-S-type
Si3N4 tip; Digital Instruments, Santa Barbara, CA, USA) with a
calibrated spring constant determined by thermal £uctuation analysis
[25] was maneuvered (100^150 nm/s) toward the immobilized proteins
on the sample stage using a Nanoscope IIIa multimode AFM (Digital
Instruments) until it touched the sample with a maximum threshold
force of 1.8 nN and a contact time of 0.5 s. During the retraction of
the sample stage, occasional downward de£ections of the AFM canti-
lever were observed. Most such de£ections were terminated with a
¢nal rupture force of 9 2 nN corresponding to the breakage of a
covalent bond after a piezo displacement relative to the tip position
corresponding to the stretching of a protein molecule up to 70^100
nm. Each experiment was repeated several times to obtain approxi-
mately 1000 such cycles and only force curves with the above char-
acteristics were collected for further F^E analysis following a proce-
dure reported earlier [26]. The experimental setup was carefully
veri¢ed either by experiments with blanks where all the possible com-
binations of modi¢ed and unmodi¢ed substrates and tips were tested,
or using spacers of di¡erent lengths and the results con¢rmed that the
force curves collected for further analysis corresponded uniquely to
protein stretching events. All AFM experiments were performed in a
liquid environment containing 50 mM Tris^SO4 (pH 7.5) at room
temperature (22^26‡C) unless otherwise stated.
2.5. Refolding of type II conformer
Denaturation and reactivation of the type II conformer were car-
ried out according to Persson et al. [27], where the reactivation bu¡er
(50 mM Tris^SO4, pH 7.5) contained 10 mM KCl, 10 mM MgSO4,
1 mM Mg^ATP and GroEL as a chaperone in a two-fold molar
excess of type II. During refolding, a fraction (approx. 10^20%) of
the protein was found aggregated and/or dimerized and, therefore, the
activity of the refolded protein was measured after HPLC separation
of such fractions together with GroEL and extra salts.
2.6. Carboxypeptidase Y (CP-Y) digestion of the conformers
Digestion of sample proteins was initiated by mixing each protein
substrate and CP-Y (Sigma, St. Louis, MO, USA) at a 5:1 molar ratio
in 0.1 M ammonium acetate bu¡er, pH 6.0, at 25‡C. At appropriate
intervals, aliquots were withdrawn from the reaction mixture and
subjected to MALDI TOF mass spectroscopic analyses (AXIMA-
CFR, Shimadzu, Tokyo, Japan) following the procedure reported
earlier to determine the extent of digestion [28].
3. Results and discussion
The puri¢ed protein (BCAIIGln253Cys) showed a single
narrow band on SDS^PAGE. The far-UV CD and £uores-
cence spectra of the engineered protein were almost indistin-
guishable from those of the wild-type enzyme. However, the
enzymatic activity was about 49% of that of a commercial
wild-type BCAII as shown in Table 1. An addition of
Zn(II) did not increase the activity signi¢cantly. The result
suggested two possibilities, (i) the particular mutation em-
ployed in this experiment reduced the activity of all the mol-
ecules to about one half of that of the wild-type enzyme, or
(ii) the sample was composed of two di¡erent conformers with
dissimilar enzymatic properties. Since our preliminary me-
chanical unfolding experiment using the engineered BCAII
(BCAIIGln253Cys) revealed the co-existence of two types of
F^E curves [29], one interacting with an enzymatic inhibitor
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and the other not, we suspected the second possibility to be
true. In order to clarify the situation, an a⁄nity matrix was
constructed by immobilizing the well-known inhibitor of the
enzyme, p-aminomethylbenzenesulfonamide, on an activated
agarose gel. The resultant matrix fractionated a solution of
BCAIIGln253Cys into a £ow-through (type II conformer) and
a column-bound (type I conformer) fraction with an approx-
imate ratio of 1:1. The matrix-bound protein was subse-
quently eluted by the addition of sodium azide (0.4 M) as a
releasing agent [23]. Thus, our hypothesis that the particular
mutation employed in this experiment caused an accumula-
tion of two conformers, one having an active site for inhibitor
binding and the other not, was supported. It was further
con¢rmed that the type I conformer was enzymatically fully
active while the type II conformer was not (Table 1). The
¢nding that the two conformers co-existed in a ratio of 1:1
was consistent with our earlier observation that the speci¢c
activity of the engineered protein was about 49% of that of
the wild-type enzyme.
3.1. Spectroscopic properties of the separated conformers
BCAII contains seven Trp residues in mainly apolar envi-
ronments and upon excitation at 280 nm, it gives a £uores-
cence emission spectrum with Vmax = 342 nm. Any alteration
of the above environment results in a red shift in emission
maxima. Fig. 2a shows the £uorescence spectrum of BCAII
along with those of the two newly found conformers (type I
and II). Close similarities in Vmax among the three indicate
that Trp residues of both conformers are situated in similar
apolar environments to those of the wild-type BCAII. Fur-
thermore, as the seven Trps are positioned in di¡erent parts of
the conformers, the observed £uorescence spectra indicated
similarities in their global conformations. The far-UV CD
spectra of the two conformers were almost identical to each
other and to that of the wild-type enzyme with very similar
K-helicities; 7.8^8.2% for all three. Fig. 2b shows the near-UV
CD spectra of the native BCAII along with those of the two
Fig. 1. The strategy for stretching the engineered protein by avoid-
ing knot tightening illustrated using the crystallographic structure of
BCAII [16].
Table 1
Esterase activity of bovine carbonic anhydrase I and II and its var-
iant and conformers
Protein Vo/[E]o (min31) Relative activity (%)
Commercial BCAII 54.0C 1 100
BCAIIGln253Cys 26.5C 1 49
Type I 52.4C 1 97
Type II 0.0 C 1 W0
Note: Vo is the rate of p-nitrophenol production in WM/min and
[E]o is the initial concentration of enzyme in WM unit. Due to the
low solubility of p-nitrophenyl acetate, Vo was measured at di¡erent
protein concentrations and averaged. The error indicates the stan-
dard deviation.
Fig. 2. Spectroscopic similarities between separated type I and II conformers of engineered BCAII. a: Intrinsic £uorescence spectra of native
(black), random coil (blue), type I (red) and type II (green) conformers in Tris^SO4 bu¡er at pH 7.5. The excitation wavelength was 280 nm
and the protein concentration was slightly di¡erent for each spectrum. When normalized with respect to concentration, the £uorescence inten-
sities of the three spectra (black, red and green) were virtually identical. b: Near-UV CD spectra of native (black), type I (red) and type II
(green) conformers in the same bu¡er.
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conformers. The CD data in this region are known to provide
information on the tertiary structure of the protein. Compar-
ison of the near-UV CD spectra indicated that the character-
istic CD bands for the wild-type enzyme and type I were al-
most identical to each other but recognizably di¡erent from
those of type II for which all the peaks and troughs were kept
almost unchanged with respect to their positions while some
of the troughs are shallower for type II. The result indicates
that all three forms had similar tertiary structures with minor
conformational deviations in type II. When the asymmetry
around the aromatic residues is partially lost as in the case
of the ‘molten globule’ form, the spectrum in this region be-
comes £at and positive [14]. It is, therefore, likely that the type
II conformer is more compactly folded than the ‘molten glob-
ule’ state, which is in accordance with the above £uorescence
result.
3.2. Chaperonin-assisted refolding of type II
To investigate whether type II had a defective covalent
structure and, therefore, was unable to form an active enzyme,
we performed chaperonin-assisted refolding experiments using
a denatured type II. It has been observed that chaperonin can
facilitate rearrangements of misfolded structures during re-
folding and unfolding of HCAII [30,31]. Our reactivation ex-
periment showed that the enzymatic activity was completely
restored if a small amount of aggregated and/or dimerized
material was discarded verifying that type II is a misfolded
conformer with the same covalent structure as type I rather
than a chemically defective species.
3.3. Mechanical unfolding of the conformers
After con¢rming the spectroscopic similarities, mechanical
unfolding experiments on type I and II were performed in
order to know the mechanics of knot-free stretching (for de-
tails, see Section 2.4 and Fig. 1). Since the stretchable part of
the protein had 254 amino acid residues including an extra
cysteine residue at its N-terminus plus two crosslinker mole-
cules, we expected to obtain F^E curves having a full exten-
sion of 94 nm (where the length of one amino acid residue was
taken as 0.37 nm). Nearly consistent with our expectation, the
F^E curves of both conformers showed much longer exten-
sions than the wild-type enzyme with some important di¡er-
ences for type I and II [17,18]. First, F^E curves of the type I
conformer had a fairly £at extension in the initial 10^15 nm
region (Fig. 3a) followed by a highly non-linear increase of
force until it reached 1.7C 0.2 nN with an average extension
of 73C 2.7 nm (n=82). We attributed this result to the suc-
cessful avoidance of knot tightening during the stretching pro-
cess. F^E curves for type II showed a relatively longer £at
extension in the initial part (30^40 nm) followed by a non-
linear increase in force until it again reached 1.7C 0.2 nN with
an almost full extension (91C 3 nm, n=75) of the chain (Fig.
3b). The ¢nal rupture forces in both cases corresponded to the
force to sever the covalent crosslinking system used in this
experiment. The small irregular bumps in the initial part of
Fig. 3. Force-induced unfolding of two independently separated conformers in a neutral bu¡er in terms of F^E curves. The engineered protein
was stretched from precisely determined sites (residue numbers 31 and 253) after being sandwiched between the tip and the substrate of AFM.
Sample proteins were extended with a mean and S.D. of 73C2.7 nm (n=82) for type I (a) and 91C3 nm (n=75) for type II (b), both having
similar ¢nal rupture forces of 1.7 C 0.2 nN. The insets represent the e¡ect of inhibitor that was added to the protein solutions for force mea-
surement. Type II F^E curves remained unchanged, whereas type I curves exhibited a dramatic change.
Fig. 4. Force curves obtained in an experimental bu¡er showing mi-
nor interactions between the tip and the substrate in the absence of
protein under various tip and substrate conditions. (i) Bare tip and
substrate, (ii) tip and substrate both functionalized with SPDP, and
(iii) Polyethyleneglycol-functionalized substrate and SPDP-function-
alized tip. Almost 70% of the force curve is similar to (a), while the
rest is similar to (b).
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some of the curves in Fig. 3 were not considered to be related
to the unfolding mechanics of the protein because similar
bumps were occasionally observed in reference experiments
without protein molecules (Fig. 4).
The possibility that F^E curves representing type I stretch-
ing were due to simultaneous extension of multiple chains of
type II molecules can be excluded because an integral multi-
plication of the latter F^E curves does not coincide with the
former. However, occasional transitions from type I to type II
curves were observed during stretching experiments (Fig. 5a),
supporting that type I is mechanically convertible to type II.
3.4. E¡ect of inhibitor on mechanical unfolding pathway
To study the mechanical response of the type I and type II
conformers to enzymatic inhibitors of BCAII, we added
p-aminomethylbenzenesulfonamide to the protein solution
during force measurements. In the presence of the inhibitor,
a remarkable change was induced in the type I F^E curves
indicating binding of the inhibitor to the protein, whereas type
II curves remained almost unchanged (insets of Fig. 3). The
new type I curves extended almost £atly in the initial 20^30
nm and then the tensile force rose abruptly from less than 200
pN to 1.7C 0.2 nN with 5^10 nm in further extension reaching
a total extension of 30C 5 nm before the ¢nal rupture. The
peak force at the end of the stretching corresponds to the
rupture event in the covalent crosslinking system. The result
is in good agreement with the mechanical response of the
wild-type BCAII observed in the presence of the same inhib-
itor [19]. The change in the type I curves con¢rmed the pres-
ence of the active site in this conformer and creation of a
‘rigid core’ structure upon inhibitor binding. A partial expla-
nation for the observed mechanical response may come from
a comparison of the temperature factors of the crystal struc-
ture indicating that, after binding the inhibitor, the central
part of the enzyme becomes more rigid and the outer shell
more labile [5,32].
3.5. What is the structural di¡erence between type I and II?
The mechanical response of the mutant protein was, gen-
erally speaking, consistent with what we expected when we
decided to stretch BCAII from Cys-253 rather than from
Cys-260, thus avoiding knot tightening under a tensile stress.
Compared with a mere 13C 2 nm extension of the wild-type
enzyme with a maximum force of 1.7 C 0.2 nN [17,18], type I
and II conformers were extended 73 and 91 nm, i.e. nearly 77
and 97% of the theoretical stretched length of the polypeptide
(94 nm), respectively. This is clearly a consequence of the knot
avoiding strategy. What was not expected was that the ex-
pressed protein was actually composed of two conformers
with signi¢cant di¡erences in their enzymatic activity and me-
chanical responses. Though unexpected, this is an interesting
¢nding and we planned to examine the origin of these di¡er-
ences.
We hypothesized that the observed di¡erences in mechan-
ical and enzymatic properties between the two conformers
resulted from a subtle structural di¡erence due to the intro-
duction of a Cys residue at the 253rd position leading to the
complete (type I) and incomplete (type II) formation of the
knot topology in the C-terminal region. This is in accordance
with the fact that completion of the C-terminal folding includ-
ing knot formation has been implicated as an important step
in the reactivation of carbonic anhydrase [4]. Our hypothesis
was supported when the reactivity of the two conformers to-
wards CP-Y was studied. It has been reported that wild-type
BCAII is poorly attacked by CP-Y [33], however, when the
C-terminal tertiary structure is perturbed (as in the denatured
state), it is readily hydrolyzed from the C-terminus [8]. We
therefore analyzed the susceptibility of the two conformers to
CP-Y by mass spectroscopy. Although the sensitivity of the
mass spectrum in this region (W30 kDa) is not high enough
to identify the removal of individual amino acid residues, it
clearly indicated that there was a gradual loss in mass until
31 063 corresponding to the removal of 17 amino acids from
Fig. 5. a: Collection of F^E curves signifying a transition from type I to type II conformer occasionally observed during force measurement.
The red and green lines represent F^E curves of type I and II, respectively. b: Partial digestion of three types of BCAII by CP-Y: (i) Type II
conformer, (ii) type I conformer and (iii) wild-type BCAII. The samples were exposed to CP-Y and the digestion mixtures were subjected to
MALDI TOF mass spectroscopic analysis at 6 and 12 h intervals (upper two panels). The lower panel shows the results of a control experi-
ment without CP-Y.
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type II, whereas type I as well as the commercial sample
remained una¡ected by CP-Y after 12 h incubation (Fig.
5b). The digestion did not proceed beyond this stage, indicat-
ing that the remaining part of type II possessed a tight con-
formation inaccessible to CP-Y. In addition, our recent results
of crystallization and X-ray analyses of type I showed that it
has a very similar 3D structure to wild-type BCAII and
HCAII including the C-terminal knot topology [16]. Although
for the type II conformer we still lack concrete evidence, the
result of the CP-Y treatment reported above showing that the
C-terminal sequence of the type II conformer was freely ac-
cessible to the protease while that of type I was not, strongly
supports an unknotted conformation for type II. Based on
these ¢ndings, we conclude that the major di¡erences in me-
chanical and enzymatic properties between the two conform-
ers resulted from a subtle structural di¡erence due to the
di¡erent degrees of completion of C-terminal conformation,
most notably, that of the knot topology.
In view of the immediate interest in the above result on the
bovine enzyme of a closely related human homolog, we ex-
tended our experiments to examine a pseudo-wild-type variant
of HCAII (HCAIIpwt) where a unique Cys at position 206
was replaced with Ser. It has been reported that the spectro-
scopic properties, stability and activity of this pseudo-wild-
type are indistinguishable from those of the wild-type enzyme
[34]. Two conformational isomers having similar enzymatic
and mechanical properties to type I and II conformers as
described for BCAII were found to accumulate in the popu-
lation, when two Cys residues were introduced at the N-ter-
minal and 253rd position as above. This indicates that a sim-
ilar mechanism for knot formation might be involved in both
cases, which is consistent with their similar refolding and ki-
netic properties as well as 3D structure. Details on the human
homolog will be reported in the future.
We think our data present a more direct link between knot
completion and the creation of the active site of the enzyme
than the previous observations. It will be interesting to delin-
eate the structural relationship between the knot completion
and the active site formation processes through detailed crys-
tallographic studies.
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